About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Chicago | 17,785 Studies Near You

Clinical TrialsChicago

Clinical Trials in Chicago

Discover 17,785 clinical trials near Chicago, Illinois. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 7901-7920 of 17,785 trials

TerminatedA Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial CancerThis study will investigate the individual safety and efficacy of two dual PI3K/mTOR inhibitors in patients with recurrent endometrial cancer.NCT01420081·Birmingham, Alabama and 50 others

Find Trials by Condition in Chicago

Breast Cancerin Chicago Lung Cancerin Chicago Prostate Cancerin Chicago Colorectal Cancerin Chicago Melanomain Chicago Leukemiain Chicago Lymphomain Chicago Pancreatic Cancerin Chicago Ovarian Cancerin Chicago Brain Cancerin Chicago Diabetes

Data from ClinicalTrials.govTerms

TerminatedEfficacy and Safety of Simtuzumab (SIM) With FOLFIRI as Second Line Treatment in Colorectal AdenocarcinomaThe primary objective of this study is to compare the additive efficacy of SIM versus placebo in combination with leucovorin (folinic acid), irinotecan, and fluorouracil (FOLFIRI)…NCT01479465·Huntsville, Alabama and 108 others

RecruitingThe ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical TrialsThe purpose of this study is to conduct a Hybrid Type 1 cluster-randomized, roll-out effectiveness-implementation trial in NCORP community oncology practice sites (N= 500 Black…NCT06756607·Jonesboro, Arkansas and 66 others

RecruitingA Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)The study is a prospective, longitudinal, non-interventional, multicenter study of participants with HNSCC who will have tissue and blood based molecular biomarker profiling…NCT06163534·Duarte, California and 31 others

CompletedADVATE Post Authorization Safety SurveillanceThe primary objective of this post-authorization safety surveillance is to measure the incidence of adverse events that are at least possibly related to ADVATE use, in subjects…NCT00214734·Phoenix, Arizona and 36 others

Not yet recruitingRiMO-HNC-NEO1: Phase 2 Study of RiMO-301 and Hypofractionated Radiotherapy With Pembrolizumab for the Neoadjuvant Treatment of Resectable, Locally Advanced Head-Neck CancerThe primary objective is to evaluate major pathologic response after RiMO-301 with hypofractionated radiotherapy and a PD-1 inhibitor (pembrolizumab), as assessed by clinical…NCT07732634·Chicago, Illinois

CompletedCisplatin With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic or Recurrent Head and Neck CancerRATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die.NCT00003809·Scottsdale, Arizona and 75 others

CompletedPrevention Study in Adult Patients Suffering From Migraine HeadachesPurpose of the study is to evaluate dose response relationship, efficacy, safety and tolerability of target doses of GSK1838262 compared to placebo in the prophylactic treatment…NCT00742209·Birmingham, Alabama and 58 others

CompletedPhase 1/2 Dose Finding and Safety Study of Ibrutinib in Pediatric Subjects With Chronic Graft Versus Host Disease (cGVHD)Dose Finding and Safety Study of Ibrutinib in Pediatric Subjects with Chronic Graft Versus Host Disease (cGVHD)NCT03790332·Duarte, California and 47 others

Active not recruitingGuideline-directed Management and Therapy (GDMT) for the Prevention of Postpartum Cardiac Dysfunction in Preeclamptic African American WomenThis is a single-center, open-label pilot study looking at how Guideline-directed management and therapy (GDMP) in post-partum women with preeclampsia can improve Global…NCT05534932·Chicago, Illinois

CompletedSteroids In Eosinophil Negative AsthmaBecause approximately half of all mild-moderately-severe asthma is persistently non-eosinophilic, it is important to determine prospectively if patients who are persistently…NCT02066298·Tucson, Arizona and 24 others

CompletedStudy of Long Term Safety and Clinical Outcomes of Idursulfase IT and Elaprase Treatment in Pediatric Participants Who Have Completed Study HGT-HIT-094This extension study will allow participants that completed Study HGT-HIT-094 to continue receiving Elaprase treatment in conjunction with idursulfase IT or to continue receiving…NCT02412787·Oakland, California and 8 others

RecruitingTelephone Support in Advanced Gastrointestinal CancerThe goal of this clinical trial is to see if telephone support programs help patients and their family caregivers adjust to advanced gastrointestinal cancer.NCT06532877·Chicago, Illinois and 3 others

CompletedPhilips Intracardiac Echocardiography (ICE) Clinical RegistryThe purpose of this observational registry is to report real-world safety and performance of VeriSight for ultrasound guided ICE imaging in percutaneous cardiac intervention…NCT04950192·Aurora, Colorado and 4 others

RecruitingThe Microbiota Augmentation to Reestablish Commensal Organisms (MARCO) TrialThe Microbiota Augmentation to Reestablish Commensal Organisms (MARCO) trial is a single center prospective adaptive phase 1b clinical trial in patients who are hospitalized with…NCT06871111·Chicago, Illinois

Active not recruitingA Phase 3 Trial of DT120 for Major Depressive Disorder (Emerge)A Phase 3 Double-blind, Placebo-controlled Study (Part A) with an Open-label Extension (Part B) Evaluating DT120 Compared to Placebo in Major Depressive Disorder - EmergeNCT06941844·Little Rock, Arkansas and 21 others

CompletedA Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)This study is open to adults who are at least 18 years old and have a body mass index (BMI) of 27 kg/m2 or more.NCT06077864·Birmingham, Alabama and 539 others

CompletedStudy to Investigate Efficacy, Safety and Pharmacokinetics of BT595 in Subjects With PIDThis Phase III clinical study is to test efficacy, safety and pharmacokinetics of BT595 in treating patients with Primary Immunodeficiency (PID)NCT02810444·Birmingham, Alabama and 18 others

Active not recruitingA Study of Zolbetuximab (IMAB362) in Adults With Pancreatic CancerZolbetuximab is being studied as a treatment for people with pancreatic cancer. Most people with pancreatic cancer have a protein called Claudin 18.2 (CLDN18.2) in their tumor.NCT03816163·Fullerton, California and 135 others

CompletedDabrafenib With or Without Trametinib in Treating Patients With Advanced Differentiated Thyroid CancerThis randomized phase II trial studies how well dabrafenib works with or without trametinib in treating patients with recurrent thyroid cancer.NCT01723202·San Diego, California and 4 others

PreviousPage 396 of 890Next

in Chicago

Heart Diseasein Chicago